Related references
Note: Only part of the references are listed.CCNE1 Promotes Progression and is Associated with Poor Prognosis in Lung Adenocarcinoma
Guoliang Ma et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2022)
Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer
Jiaqi Zhu et al.
DISEASE MARKERS (2022)
A Novel Prognostic Predictor of Immune Micro-environment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature
Wenwei Chen et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2022)
Identification of SRXN1 and KRT6A as Key Genes in Smoking-Related Non-Small-Cell Lung Cancer Through Bioinformatics and Functional Analyses
Jiazhen Zhou et al.
FRONTIERS IN ONCOLOGY (2022)
REC8 inhibits proliferation, migration and invasion of breast cancer cells by targeting CDC20
Shaodan He et al.
MOLECULAR MEDICINE REPORTS (2022)
TRIP13 Induces Nedaplatin Resistance in Esophageal Squamous Cell Carcinoma by Enhancing Repair of DNA Damage and Inhibiting Apoptosis
Lin-Ting Zhang et al.
BIOMED RESEARCH INTERNATIONAL (2022)
FGA Controls VEGFA Secretion to Promote Angiogenesis by Activating the VEGFR2-FAK Signalling Pathway
Hui Li et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Aberrant Expression of BUB1B Contributes to the Progression of Thyroid Carcinoma and Predicts Poor Outcomes for Patients
Hai-Chao Yan et al.
JOURNAL OF CANCER (2022)
Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma
Yinfei Tan et al.
CLINICAL CANCER RESEARCH (2021)
Targeting mutant p53 for cancer therapy: direct and indirect strategies
Jiahao Hu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Genomic, Immunological, and Clinical Characterization of Pyroptosis in Ovarian Cancer
Min Zhou et al.
JOURNAL OF INFLAMMATION RESEARCH (2021)
Increased tensin 4 expression is related to the histological type of gastric cancer
Marcin Niziol et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2021)
MiR-532-3p suppresses cell viability, migration and invasion of clear cell renal cell carcinoma through targeting TROAP
Bin Gao et al.
CELL CYCLE (2021)
Current and Future Development in Lung Cancer Diagnosis
Reem Nooreldeen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
IL-6/STAT3 signaling pathway regulates the proliferation and damage of intestinal epithelial cells in patients with ulcerative colitis via H3K27ac
Yanrong Li et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
Necroptosis in Esophageal Squamous Cell Carcinoma: An Independent Prognostic Factor and Its Correlation with Tumor-Infiltrating Lymphocytes
Takuro Yamauchi et al.
CANCERS (2021)
m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer
Bo Zhang et al.
MOLECULAR CANCER (2020)
Genetic Markers in Lung Cancer Diagnosis: A Review
Katarzyna Wadowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Risk-Based lung cancer screening: A systematic review
Iakovos Toumazis et al.
LUNG CANCER (2020)
Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC)-novel approaches and future outlook
Lena Horvath et al.
MOLECULAR CANCER (2020)
Expression of key regulatory genes in necroptosis and its effect on the prognosis in non-small cell lung cancer
Ji Eun Park et al.
JOURNAL OF CANCER (2020)
The role of necroptosis in cancer biology and therapy
Yitao Gong et al.
MOLECULAR CANCER (2019)
RIP1/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review)
Yuping Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2019)
Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity
Annelise G. Snyder et al.
SCIENCE IMMUNOLOGY (2019)
A Phase II Trial of Osimertinib in the Second-Line Treatment of Non-small Cell Lung Cancer with the EGFR T790M Mutation, Detected from Circulating Tumor DNA: LiquidLung-O-Cohort 2
Cheol-Kyu Park et al.
CANCER RESEARCH AND TREATMENT (2019)
Patient and carer perceived barriers to early presentation and diagnosis of lung cancer: a systematic review
Shemana Cassim et al.
BMC CANCER (2019)
Pyroptosis versus necroptosis: similarities, differences, and crosstalk
Daniel Frank et al.
CELL DEATH AND DIFFERENTIATION (2019)
Update on Immunohistochemistry for the Diagnosis of Lung Cancer
Kentaro Inamura
CANCERS (2018)
Necroptosis microenvironment directs lineage commitment in liver cancer
Marco Seehawer et al.
NATURE (2018)
The biology and management of non-small cell lung cancer
Roy S. Herbst et al.
NATURE (2018)
Mutant p53 as a target for cancer treatment
Michael J. Duffy et al.
EUROPEAN JOURNAL OF CANCER (2017)
Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells
Hyo-Jin Kim et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Initiation and execution mechanisms of necroptosis: an overview
Sasker Grootjans et al.
CELL DEATH AND DIFFERENTIATION (2017)
The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression
Lena Seifert et al.
NATURE (2016)
Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis
Boris Strilic et al.
NATURE (2016)
CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis
Ting Zhang et al.
NATURE MEDICINE (2016)
Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity
Tania Love Aaes et al.
CELL REPORTS (2016)
Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics
Gi-Bang Koo et al.
CELL RESEARCH (2015)
Absence of RIPK3 predicts necroptosis resistance in malignant melanoma
P. Geserick et al.
CELL DEATH & DISEASE (2015)
Necroptosis Interfaces with MOMP and the MPTP in Mediating Cell Death
Jason Karch et al.
PLOS ONE (2015)
Receptor-interacting protein kinase 3 is a predictor of survival and plays a tumor suppressive role in colorectal cancer
X. Feng et al.
NEOPLASMA (2015)
Regulated cell death and inflammation: an auto-amplification loop causes organ failure
Andreas Linkermann et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma
Lauren E. Colbert et al.
CANCER (2013)
Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis
Jianfeng Wu et al.
CELL RESEARCH (2013)
Low expression of mixed lineage kinase domain-like protein is associated with poor prognosis in ovarian cancer patients
Fu-fan Zhu et al.
OncoTargets and Therapy (2013)
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
Julian R. Molina et al.
MAYO CLINIC PROCEEDINGS (2012)
Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis
Claudia Guenther et al.
NATURE (2011)
Genetic Predisposition in Degenerative Lumbar Scoliosis due to the Copy Number Variation
Jae-Hyuk Shin et al.
SPINE (2011)
Molecular mechanisms of necroptosis: an ordered cellular explosion
Peter Vandenabeele et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation
YoungSik Cho et al.
CELL (2009)
Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
Sudan He et al.
CELL (2009)
RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis
Duan-Wu Zhang et al.
SCIENCE (2009)
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
P Scaffidi et al.
NATURE (2002)
Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule
N Holler et al.
NATURE IMMUNOLOGY (2000)